Javascript must be enabled to continue!
Hymenoptera Venom Anaphylaxis
View through CrossRef
Systemic reactions to insect sting can be life-threatening. Life-threatening systemic reactions to insect sting are estimated to occur in 0.4% to 0.8 % of children and in 3 % of adults. Hymenoptera stings that includes Apoidea (bees), Vespoidea (wasps, hornets, and yellow jackets), and Formicidae (ants) cause more deaths than other insects all over the world. Hymenoptera venom include mixtures of numerous relevant allergens .The diagnosis of venom allergy is based on both of clinical history and positive skin test response, and/or specific immunoglobulin E antibodies. Allergic reactions may develop after stinging by hymenoptera venom. It is ranging from local up to severe systemic reactions and even fatal anaphylaxis. The treatment of large local reactions is oral antihistamines and corticosteroid therapy. Patients with any signs or symptoms of anaphylaxis should immediately receive epinephrine intramuscularly, emergency medical attention and treatment. After acute treatment of a sting reaction, patients should be given a prescription for an epinephrine autoinjector. Patients with experiences of systemic reactions after hymenoptera venom sting with positive specific IgE should receive venom immunotherapy. Venom immunotherapy is the only causal treatment to prevent further systemic sting reactions. The protective rate of venom immunotherapy is reported 98% in patients with had venom anaphylaxis history.
Title: Hymenoptera Venom Anaphylaxis
Description:
Systemic reactions to insect sting can be life-threatening.
Life-threatening systemic reactions to insect sting are estimated to occur in 0.
4% to 0.
8 % of children and in 3 % of adults.
Hymenoptera stings that includes Apoidea (bees), Vespoidea (wasps, hornets, and yellow jackets), and Formicidae (ants) cause more deaths than other insects all over the world.
Hymenoptera venom include mixtures of numerous relevant allergens .
The diagnosis of venom allergy is based on both of clinical history and positive skin test response, and/or specific immunoglobulin E antibodies.
Allergic reactions may develop after stinging by hymenoptera venom.
It is ranging from local up to severe systemic reactions and even fatal anaphylaxis.
The treatment of large local reactions is oral antihistamines and corticosteroid therapy.
Patients with any signs or symptoms of anaphylaxis should immediately receive epinephrine intramuscularly, emergency medical attention and treatment.
After acute treatment of a sting reaction, patients should be given a prescription for an epinephrine autoinjector.
Patients with experiences of systemic reactions after hymenoptera venom sting with positive specific IgE should receive venom immunotherapy.
Venom immunotherapy is the only causal treatment to prevent further systemic sting reactions.
The protective rate of venom immunotherapy is reported 98% in patients with had venom anaphylaxis history.
Related Results
The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice
The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice
Background: Hymenoptera venom allergy is an immunoglobulin (Ig) E mediated hypersensitivity reaction to Hymenoptera venoms. Obvious identification of the culprit insect that causes...
Integrative multi-omics analysis reveals the contribution of neoVTX genes to venom diversity of Synanceia verrucosa
Integrative multi-omics analysis reveals the contribution of neoVTX genes to venom diversity of Synanceia verrucosa
Abstract
Background
Animal venom systems have been considered as valuable model for investigating molecular mechanisms underlying phenotypic evolution. The stonefish were ...
Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy
Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy
Objectives
Little is known about the Hymenoptera venom allergy impact on work ability and the effect of venom immunotherapy (VIT) on work. The objective of this...
A Quality-of-life Study in Patients with Anaphylaxis to Hymenoptera Venom in Iran
A Quality-of-life Study in Patients with Anaphylaxis to Hymenoptera Venom in Iran
Little is known about the quality of life of patients with anaphylaxis to Hymenoptera venom. The Vespid Allergy Quality of Life Questionnaire (VQLQ) is commonly used to assess the ...
Trends in Childhood Anaphylaxis in Singapore: 2015–2022
Trends in Childhood Anaphylaxis in Singapore: 2015–2022
ABSTRACTBackgroundThere has been limited data regarding the incidence of anaphylaxis in Asia. We aim to describe patterns in patient characteristics, triggers and clinical presenta...
EVALUATION OF BARU (DIPTERYX ALATA) FLOUR AS A POTENTIAL INHIBITOR OF THE LACHESIS MUTA MUTA SNAKE VENOM -INDUCED MYOTOXICITY AND NEUROMUSCULAR BLOCKADE
EVALUATION OF BARU (DIPTERYX ALATA) FLOUR AS A POTENTIAL INHIBITOR OF THE LACHESIS MUTA MUTA SNAKE VENOM -INDUCED MYOTOXICITY AND NEUROMUSCULAR BLOCKADE
Snake venom is a complex mixture of bioactive substances known to induce a wide range of toxic effects. We investigated the potential of baru flour (Dipteryx alata) in mitigating t...
EPIDEMIOLOGY OF ANAPHYLAXIS IN COLOMBIA 2010-2015
EPIDEMIOLOGY OF ANAPHYLAXIS IN COLOMBIA 2010-2015
ABSTRACT
Background
The lifetime prevalence of anaphylaxis from all triggers is estimated to range from 0.05 % to 2.6 %. Data o...
Recurrent anaphylaxis in the United States: time of onset and risk factors
Recurrent anaphylaxis in the United States: time of onset and risk factors
BackgroundStudies have not yet examined the trends and risk factors of biphasic and recurrent anaphylaxis in the United States using International Classification of Diseases, tenth...

